Stocks · Health care · Pharmaceutical Preparations

Lifevantage Corp

LFVN Clue Score55

United States Fiscal year ends December CIK 0000849146 Results filed 27 Aug 2026

Add to watchlist

What the insiders did Net selling

By person

14 insiders · 14 transactions

Insider

Role

Bought

Sold

Net

Holding

Of company

Worth

Change

Michael A Beindorff

Director

—

$415.98K (4)

−$415.98K

69,195

0.5524%

$430.39K

−40.7%

Judd Dayton

Director

$152.42K (3)

—

+$152.42K

80,359

0.6415%

$499.83K

+211.3%

Kristen Cunningham

Chief Sales Officer

—

$55.65K (2)

−$55.65K

152,375

1.22%

$947.77K

+40.7%

Darwin Lewis

Director

$43.56K (5)

—

+$43.56K

138,244

1.10%

$859.88K

+27.6%

Steven R Fife

President and CEO

—

—

—

735,471

5.87%

$4.57M

+8.7%

Terrence Moorehead

President and CEO

—

—

—

501,879

4.01%

$3.12M

—

Carl Aure

Chief Financial Officer

—

—

—

191,784

1.53%

$1.19M

+33.3%

Julie Boyster

Chief Marketing Officer

—

—

—

150,088

1.20%

$933.55K

+27.0%

Raymond B Greer

Director

—

—

—

112,819

0.9006%

$701.73K

+13.4%

Alissa Neufeld

General Counsel

—

—

—

112,744

0.9000%

$701.27K

+22.1%

Garry Paul Mauro

Director

—

—

—

92,685

0.7399%

$576.50K

+12.1%

Cynthia Latham

Director

—

—

—

64,879

0.5179%

$403.55K

+35.2%

Todd Thompson

Chief Information Officer

—

—

—

50,729

0.4049%

$315.53K

−1.2%

Rajendran Anbalagan

Director

—

—

—

23,999

0.1916%

$149.27K

+806.0%